ME
AGN

McIlrath & Eck’s Allergan plc AGN Stock Holding History

McIlrath & Eck’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-708
Closed -$125K – 742
2020
Q1 		$125K Buy
708
+20
+3% +$3.77K 0.07% 57
2019
Q4 		$132K Hold
688
– – 0.06% 61
2019
Q3 		$116K Sell
688
-8
-1% -$1.3K 0.06% 63
2019
Q2 		$102K Hold
696
– – 0.06% 70
2019
Q1 		$102K Hold
696
– – 0.06% 70
2018
Q4 		$93K Buy
696
+688
+8,600% +$113K 0.06% 72
2018
Q3 		$2K Hold
8
– – ﹤0.01% 483
2018
Q2 		$1K Hold
8
– – ﹤0.01% 505
2018
Q1 		$1K Hold
8
– – ﹤0.01% 467
2017
Q4 		$1K Buy
+8
New +$1.44K ﹤0.01% 507

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

McIlrath & Eck's AGN Position: Q2 2020 in Review

McIlrath & Eck sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 708 shares — an estimated $125K sold.

McIlrath & Eck first reported a position in AGN in Q4 2017 and held it in 10 quarters. The position peaked at $132K in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • McIlrath & Eck reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • McIlrath & Eck sold 708 Allergan plc shares in Q2 2020, an estimated $125K.
  • McIlrath & Eck first reported a position in Allergan plc in Q4 2017 and held it in 10 quarters.
  • McIlrath & Eck's Allergan plc position peaked at $132K in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on McIlrath & Eck's 13F filing for Q2 2020, filed 4 Aug 2020.